During the past decade, Creekside Endocrine Associates, PC conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 14 clinical trials were completed, i.e. on average, 93.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 8 clinical trials were completed. i.e. 266.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Creekside Endocrine Associates, PC" #1 sponsor was "Boehringer Ingelheim" with 2 trials, followed by "Kowa Research Institute, Inc." with 2 trials sponsored, "Mannkind Corporation" with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "Akebia Therapeutics" with 2 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Creekside Endocrine Associates, PC" #1 collaborator was "Integrium" with 3 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Barc NV" with 1 trials as a collaborator, "Cyclerion Therapeutics" with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Creekside Endocrine Associates, PC" are "Type 2 Diabetes Mellitus" (4 trials), "Chronic Kidney Disease" (2 trials), "Diabetes Mellitus, Type 1" (2 trials), "Hyperlipidemia" (2 trials) and "Severe Hypertriglyceridemia" (2 trials). Many other conditions were trialed in "Creekside Endocrine Associates, PC" in a lesser frequency.

Most popular intervention types in "Creekside Endocrine Associates, PC" are "Drug" (22 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Fenofibrate" (2 trials), "K-877" (2 trials), "Placebo (for K-877)" (2 trials) and "AC2993" (1 trials). Other intervention names were less common.

The vast majority of trials in "Creekside Endocrine Associates, PC" are 21 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Creekside Endocrine Associates, PC". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in Creekside Endocrine Associates, PC, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Creekside Endocrine Associates, PC, 1 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".